About Agilon Health, Inc. 
Agilon Health, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 57 Schemes (62.56%)
Foreign Institutions
Held by 126 Foreign Institutions (9.12%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1,420 Million
(Quarterly Results - Mar 2026)
Net Profit:
30 Million
Pharmaceuticals & Biotechnology
USD 247 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.90
-102.82%
0.81






